Tested Applications
| Positive WB detected in | mouse brain tissue |
| Positive IP detected in | HeLa cells |
| Positive IHC detected in | human gliomas tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:1000-1:4000 |
| Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
17693-1-AP targets ABL2 in WB, IHC, IF, IP, CoIP, ELISA applications and shows reactivity with human, mouse samples.
| Tested Reactivity | human, mouse |
| Cited Reactivity | human, mouse, rat |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag11860 Product name: Recombinant human ABL2 protein Source: e coli.-derived, PET28a Tag: 6*His Domain: 822-1167 aa of BC065912 Sequence: SEESAAPSRERPKAKLLPRGATALPLRTPSGDLAITEKDPPGVGVAGVAAAPKGKEKNGGARLGMAGVPEDGEQPGWPSPAKAAPVLPTTHNHKVPVLISPTLKHTPADVQLIGTDSQGNKFKLLSEHQVTSSGDKDRPRRVKPKCAPPPPPVMRLLQHPSICSDPTEEPTALTAGQSTSETQEGGKKAALGAVPISGKAGRPVMPPPQVPLPTSSISPAKMANGTAGTKVALRKTKQAAEKISADKISKEALLECADLLSSALTEPVPNSQLVDTGHQLLDYCSGYVDCIPQTRNKFAFREAVSKLELSLQELQVSSAAAGVPGTNPVLNNLLSCVQEISDVVQR Predict reactive species |
| Full Name | v-abl Abelson murine leukemia viral oncogene homolog 2 (arg, Abelson-related gene) |
| Calculated Molecular Weight | 1167 aa, 127 kDa |
| Observed Molecular Weight | 128-140 kDa |
| GenBank Accession Number | BC065912 |
| Gene Symbol | ABL2 |
| Gene ID (NCBI) | 27 |
| RRID | AB_2289025 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P42684 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
ABL2(Abelson tyrosine-protein kinase 2) is also named as ABLL, ARG and belongs to the protein kinase superfamily. It is a membrane-anchored nonreceptor tyrosine kinase that is a novel mediator of SEMA3F-induced RhoA inactivation and collapsing activity and it has a role in cytoskeletal rearrangements by its C-terminal F-actin- and microtubule-binding sequences. ABL2 can be polyubiquitinated and the polyubiquitination of ABL2 leads to degradation. This protein has 9 isoforms produced by alternative splicing with the molecular weight from 114 kDa to 128 kDa. The antibody is specific to the others except the 60 kDa isoform of ABL2.
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for ABL2 antibody 17693-1-AP | Download protocol |
| IP protocol for ABL2 antibody 17693-1-AP | Download protocol |
| WB protocol for ABL2 antibody 17693-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The ABL2 Polyclonal antibody (Cat# 17693-1-AP) has 15 citations. These appear in journals including Signal Transduction and Targeted Therapy, Bioactive Materials, Theranostics, Cancer Letters, Oncogene, International Journal of Nanomedicine, International Journal of Biological Macromolecules, Cell Reports, Biochimica et Biophysica Acta, Genomics, Kaohsiung Journal of Medical Sciences, Journal of Neuroimmunology, Addictive Biology, American Journal of Translational Research, and eLife. Research fields span oncology (HCC, bladder, renal, breast cancer), neuroscience, cardiovascular disease, diabetes, bone biology, and muscle development.
| Species | Application | Title |
|---|---|---|
Signal Transduct Target Ther Revealing the crucial roles of suppressive immune microenvironment in cardiac myxoma progression. | ||
Bioact Mater High proportion strontium-doped micro-arc oxidation coatings enhance early osseointegration of titanium in osteoporosis by anti-oxidative stress pathway. | ||
Theranostics Non-invasive photobiomodulation treatment in an Alzheimer Disease-like transgenic rat model. | ||
Cancer Lett A synergistic regulation works in matrix stiffness-driven invadopodia formation in HCC | ||
Oncogene Phosphorylation of MICAL2 by ARG promotes head and neck cancer tumorigenesis by regulating skeletal rearrangement | ||
Int J Nanomedicine Intravenous Injection of Na Ions Aggravates Ang II-Induced Hypertension-Related Vascular Endothelial Injury by Increasing Transmembrane Osmotic Pressure
|







